Table 1.

Baseline characteristics of patients who underwent endoscopic ultrasound-guided celiac plexus neurolysis [n (%), n = 58]

Independent variables	Total number
Age in yr, range (mean)	54–73 (67)
Gender, female/male	25/33
Symptom
Abdominal pain concomitant with jaundice Tumor largest dimension in mm, range (mean)	6 (10.3)
Ascites, slight or mild	24–100 (44.3)
Tumor location	4 (6.9)
Pancreatic head/neck
Pancreatic body/tail	18 (31.0)
Initial VAS score, range (mean)	40 (69.0)
Tramadol use before EUS-CPN	6-10 (8)
Dose in mg, range (mean)	51 (87.9)
Ganglia visualized	0-240 (40)
Invasion of celiac plexus	42 (72.4)
Distant metastasis	16 (27.6)
Injected alcohol dose in mL, range (mean)	26 (44.8)
Procedure method	5–20 (10)
Unilateral
Bilateral	33 (56.9)
Intra-procedural decrease in heart rate	25 (43.1)
decrease of ≥ 5 beats for ≥ 10 s
	48 (82.8)

EUS-CPN: Endoscopic ultrasound-guided celiac plexus neurolysis; VAS: Visual analog scale.